Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
PhaseBio Pharmaceuticals (PHASQ)
- 0.000000
- 0.0000000.00%
15min DelayClose Apr 14 09:30 ET
0Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000000Prev Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)49.86MShares0.00000052wk High0.00P/B0Float Cap0.00000052wk Low--Dividend TTM34.41MShs Float16.650000Historical High--Div Yield TTM0.00%Range %0.000001Historical Low--Avg Price1Lot Size
PhaseBio Pharmaceuticals (PHASQ) Key Financial Indicators
PHASQ Earnings per Share (EPS)
According to the latest financial report of PhaseBio Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.34. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
PHASQ Free Cash Flow (FCF)
Interested in knowing about PhaseBio Pharmaceuticals's free cash flow? The latest report shows it as -10.47M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
PHASQ Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of PhaseBio Pharmaceuticals shows that the company's current ratio is 0.47, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
PHASQ Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of PhaseBio Pharmaceuticals, the quick ratio is 0.32, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
PHASQ Return on Equity (ROE)
Want to learn more about the financial health of PhaseBio Pharmaceuticals? The latest ROE figure is -163.56%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
PHASQ Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of PhaseBio Pharmaceuticals, the total asset return on investment (ROA) is -54.79%.
Currency: USD
Quarterly
Loading...
PHASQ Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check PhaseBio Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
PHASQ Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of PhaseBio Pharmaceuticals, the net profit margin is -8.01K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm